Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 5, 2013, Pages 483-490

  Lo, Wai Kit ^a,b   Chan, Walter W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Drug; Hypochlorhydria; Reflux; Side Effect; Small Bowel Flora

Indexed keywords

ESOMEPRAZOLE; GLUCOSE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE;

ASPIRATION; BACTERIAL OVERGROWTH; COCHRANE LIBRARY; DATA EXTRACTION; DATA SYNTHESIS; EMBASE; GLUCOSE TOLERANCE TEST; HUMAN; HYDROGEN BREATH TEST; INTESTINE FLORA; IRRITABLE COLON; MALABSORPTION; MEDICAL SUBJECT HEADINGS; MEDLINE; META ANALYSIS; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PRETEST POSTTEST DESIGN; PUBLISHING; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CONTROL; SYSTEMATIC REVIEW;

BACTERIAL INFECTIONS; HUMANS; INTESTINE, SMALL; PROTON PUMP INHIBITORS; RISK ASSESSMENT; SUPERINFECTION;

EID: 84876711968     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.12.011     Document Type: Review

References (44)

1. IMS Health reports US prescription sales grew 5.1 percent in 2009, to $300.3 billion. Press release. IMS health IMS Health, Accessed April 1, 2010. http://www.imshealth.com/portal/site/imshealth/menuitem.a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=d690a27e9d5b7210VgnVCM100000ed152ca2RCRD&vgnextchannel=41a67900b55a5110VgnVCM10000071812ca2RCRD&vgnextfmt=default.
2. Bartholow M. Top 200 prescription drugs of 2009. Pharmacy Times, 2010 http://www.pharmacytimes.com/issue/pharmacy/2010/May2010/RxFocusTopDrugs-0510.
3. Yachimski P.S., Farrell E.A., Hunt D.P., et al. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice. Arch Intern Med 2010, 170:779-783.
4. Cook D., Heyland D., Griffith L., et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 1999, 27:2812-2817.
5. Kirsch M. Bacterial overgrowth. Am J Gastroenterol 1990, 85:231-237.
6. Williams C. Occurrence and significance of gastric colonization during acid-inhibitory therapy. Best Pract Res Clin Gastroenterol 2001, 15:511-521.
7. Theisen J., Nehra D., Citron D., et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 2000, 4:50-54.
8. Pereira S.P., Gainsborough N., Dowling R.H. Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly. Aliment Pharmacol Ther 1998, 12:99-104.
9. Rana S.V., Bhardwaj S.B. Small intestinal bacterial overgrowth. Scand J Gastroenterol 2008, 43:1030-1037.
10. Hoffmann J.C., Zeitz M. Small bowel disease in the elderly: diarrhoea and malabsorption. Best Pract Res Clin Gastroenterol 2002, 16:17-36.
11. Husebye E., Skar V., Høverstad T., et al. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut 1992, 33:1331-1337.
12. Welage L.S., Carver P.L., Revankar S., et al. Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin Infect Dis 1995, 21:1431-1438.
13. Fried M., Siegrist H., Freil R., et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 1994, 35:23-26.
14. Nelis G.F., Engelage A.H., Samson G. Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacterial overgrowth?. Neth J Med 1994, 45:93-100.
15. Lewis S.J., Franco S., Young G., et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther 1996, 10:557-561.
16. Thorens J., Froehlich F., Schwizer W., et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996, 39:54-59.
17. Hutchinson S., Logan R. The effect of long-term omeprazole on the glucose-hydrogen breath test in elderly patients. Age Ageing 1997, 26:87-89.
18. Law D., Pimentel M. Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS. Dig Dis Sci 2010, 55:2302-2308.
19. Lombardo L., Foti M., Ruggia O., et al. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010, 8:504-508.
20. Choung R.S., Ruff K.C., Malhotra A., et al. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011, 33:1059-1067.
21. Compare D., Pica L., Rocco A., et al. Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest 2011, 41:380-386.
22. Ratuapli S.K., Ellington T.G., O'Neill M.T., et al. Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol 2012, 107:730-735.
23. Spiegel B.M., Chey W.D., Chang L. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?. Am J Gastroenterol 2008, 103:2972-2976.
24. Wells G.A., Shea B., O'Connell D., et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
25. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
26. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
27. Gough A., Andrews D., Bacon P.A., et al. Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma. Br J Rheumatol 1995, 34:976-977.
28. Eurich D.T., Sadowski C.A., Simpson S.H., et al. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med 2010, 123:47-53.
29. Targownik L.E., Lix L.M., Metge C.J., et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008, 179:319-326.
30. Leonard J., Marshall J.K., Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007, 102:2047-2056.
31. Textbook of clinical gastroenterology and hepatology 2012, 308. Wiley-Blackwell, Hoboken, NJ. C.J. Hawkey, K. Bosch, J.E. Richter (Eds.).
32. Donald I.P., Kitchingmam G., Donald F., et al. The diagnosis of small bowel bacterial overgrowth in elderly patients. J Am Geriatr Soc 1992, 40:692-696.
33. Strocchi A., Furne J., Ellis C., et al. Methanogens outcompete sulphate reducing bacteria for H2 in the human colon. Gut 1994, 35:1098-1101.
34. Romagnuolo J., Schiller D., Bailey R.J. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol 2002, 97:1113-1126.
35. Khohsini R., Dai S.C., Lezcano S., et al. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008, 53:1443-1454.
36. Sullivan A., Törnblom H., Lindberg G., et al. The micro-flora of the small bowel in health and disease. Anaerobe 2003, 9:11-14.
37. Bouhnik Y., Alain S., Attar A., et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 1999, 94:1327-1331.
38. Dukowicz A.C., Lacy B.E., Levine G.M. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol 2007, 3:112-122.
39. Pyleris E., Giamarellos-Bourboulis E.J., Tzivras D., et al. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012, 57:1321-1329.
40. Sachdeva S., Rawat A.K., Reddy R.S., et al. Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors. J Gastroenterol Hepatol 2011, 26(Suppl 3):135-138.
41. Reddymasu S.C., Sostarich S., McCallum R.W. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?. BMC Gastroenterol 2010, 10:23.
42. Ford A.C., Spiegel B.M., Talley N.J., et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009, 7:1279-1286.
43. Shah E.D., Basseri R.J., Chong K., et al. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci 2010, 55:2441-2449.
44. Posserud I., Stotzer P.O., Björnsson E.S., et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007, 56:802-808.